Skip to main content
Figure 3 | Radiation Oncology

Figure 3

From: Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma

Figure 3

Vorinostat, capecitabine, and ionizing radiation (IR) – in vivo tumor growth. Mice bearing (A) SW620 and (B) HCT116 xenografts were treated with vehicle (control, C), vorinostat (VOR), capecitabine (CAP), IR, capecitabine and IR (CAP-IR), vorinostat and IR (VOR-IR), or vorinostat, capecitabine and IR (VOR-CAP-IR). Relative tumor volumes (mean ± SEM) presented as function of time after start of treatments.

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us